185个统战联系点直通民企“最前线”

Group 1 - The Guizhou Provincial United Front Work Department has selected 185 private enterprises as "contact points for non-public economic united front work," aiming to enhance service and support for these businesses [1][2] - Guizhou Shengnuo Biotechnology Co., Ltd. has developed a class 1 innovative drug, Succinic Acid Linagliptin Capsules, which is set to be approved for market release on December 1, 2024, after ten years of research and development [1] - The company faced significant challenges, including high R&D costs, long timelines, and uncertainty regarding inclusion in the national medical insurance directory, which is crucial for patient access [1] Group 2 - The provincial government has implemented a mechanism to provide targeted support for private enterprises, including customized financing solutions and proactive communication with various departments [2] - The mechanism has created a closed-loop process for addressing enterprise needs, allowing for direct communication of business challenges to decision-makers [2] - The Guizhou Qixin Industrial Co., Ltd. coal deep processing project faced financing difficulties but received support from the provincial government, leading to a production capacity of 1.2 million tons of coke and 200,000 tons of synthetic ammonia, generating an annual output value of 4 billion yuan [3] Group 3 - The initiative has resulted in the collection of over 100 issues from 95 private enterprises, with significant project signings at the Guizhou Business Development Conference totaling 34.4 billion yuan [3] - The established contact points serve as a network to facilitate both common policy implementation and tailored solutions for individual enterprises, promoting collaboration across the industry [3]